BDX Becton, Dickinson And Co.
$193.48
$2.74
(1.44%)
EarningsNov 5
Mkt Cap$51.96B
Vol383,801.00
About BDX
Becton, Dickinson and Company. The Group's principal activities are to manufacture and sell medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through three Segments: Medical, Diagnostics and Biosciences. Medical Segment manufactures hypodermic syringes and needles, infusion therapy devices, anesthesia needles, critical care systems and thermometers. The products manufactured by the Diagnostics Segment are integrated systems for specimen collection, safety-engineered blood collection products and systems, molecular testing systems and others. Biosciences Segment produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. Its products are marketed in the United States, Europe, Japan, Asia Pacific, Canada and Latin American countries. On 19-Nov-2009, it acquired HandyLab Inc.
Fundamentals
55
Bullish Sentiment
How do you feel about BDX?
Advertisement|Remove ads.
StocktwitsPolls17
29
NFLX57
92StocktwitsPolls25
87Advertisement|Remove ads.